Pro Share Advisors LLC Cytom X Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$1.53 - $2.89 $28,923 - $54,632	-18,904 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$2.67 - $4.68 $11,796 - $20,676	-4,418 Reduced 18.94%	18,904 $51,000
Q4 2021 Feb 08, 2022	BUY	$3.87 - $7.39 $4,218 - $8,055	1,090 Added 4.9%	23,322 $102,000
Q3 2021 Nov 12, 2021	SELL	$4.32 - $6.43 $27,112 - $40,354	-6,276 Reduced 22.01%	22,232 $113,000
Q2 2021 Aug 13, 2021	BUY	$6.33 - $9.91 $19,623 - $30,721	3,100 Added 12.2%	28,508 $180,000
Q1 2021 May 14, 2021	BUY	$6.6 - $9.0 $54,582 - $74,430	8,270 Added 48.26%	25,408 $196,000
Q4 2020 Feb 09, 2021	BUY	$6.47 - $7.9 $26,895 - $32,840	4,157 Added 32.02%	17,138 $112,000
Q3 2020 Nov 13, 2020	SELL	$6.55 - $8.83 $3,235 - $4,362	-494 Reduced 3.67%	12,981 $86,000
Q2 2020 Aug 03, 2020	BUY	$7.4 - $14.64 $99,715 - $197,274	13,475 New	13,475 $112,000
Q1 2020 May 15, 2020	SELL	$3.61 - $8.6 $57,507 - $136,998	-15,930 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$5.17 - $8.91 $7,418 - $12,785	-1,435 Reduced 8.26%	15,930 $132,000
Q3 2019 Nov 12, 2019	SELL	$7.38 - $12.25 $4,243 - $7,043	-575 Reduced 3.21%	17,365 $128,000
Q2 2019 Aug 13, 2019	SELL	$9.35 - $11.41 $20,785 - $25,364	-2,223 Reduced 11.03%	17,940 $201,000
Q1 2019 May 15, 2019	BUY	$9.5 - $19.16 $2,090 - $4,215	220 Added 1.1%	20,163 $217,000
Q4 2018 Feb 14, 2019	SELL	$12.69 - $18.61 $48,729 - $71,462	-3,840 Reduced 16.15%	19,943 $301,000
Q3 2018 Nov 14, 2018	BUY	$18.04 - $26.41 $42,069 - $61,588	2,332 Added 10.87%	23,783 $440,000
Q2 2018 Aug 13, 2018	SELL	$21.38 - $29.68 $448 - $623	-21 Reduced 0.1%	21,451 $490,000
Q1 2018 May 14, 2018	SELL	$21.76 - $34.22 $76,899 - $120,933	-3,534 Reduced 14.13%	21,472 $611,000
Q4 2017 Feb 14, 2018	BUY	$19.0 - $23.09 $475,114 - $577,388	25,006	25,006 $528,000

Others Institutions Holding CTMX

# of Institutions

Shares Held

50.4M

Call Options Held

112K

Put Options Held

8.3K

Tang Capital Management LLC San Diego, CA

7.81M
Shares

$6.95 Million
0.79% of portfolio
Bvf Inc San Francisco, CA

5.23M
Shares

$4.65 Million
0.2% of portfolio
Vanguard Group Inc Valley Forge, PA

5.16M
Shares

$4.59 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

4.81M
Shares

$4.28 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.1M
Shares

$2.76 Million
0.01% of portfolio

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $58.7M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account